Analyst Consensus ?
1 unmapped firm rating excluded from the percentages.
Best Buy Co., Inc. · BBY · FY2027 Q1 · Calendar Q2 2026
Best Buy delivered a stronger-than-expected Q1 FY27, with revenue of $8.94 billion, 2% comparable sales growth, and 11% EPS growth, beating consensus on both the top and bottom lines. Gaming, computing, and mobile phones drove demand, while the high-margin Best Buy Ads and Marketplace businesses emerged as increasingly significant growth engines. Management reaffirmed full-year FY27 guidance and outlined initiatives including an exclusive RGB TV launch, new medium and small-format stores, Meta Labs deployments in 50 locations, and AI partnerships with OpenAI and Google. CEO succession was announced with Jason Bonfig set to take over in November.
Best Buy Co., Inc. operates as a prominent technology retailer across the United States and Canada. Its business structure is segmented into Domestic and International operations. The company's extensive product selection includes a wide array of computing devices such as desktops, notebooks, and associated peripherals, alongside mobile phones (which generate commissions from network carriers), networking equipment, and tablets (including e-readers). Customers can also find smartwatches and various consumer electronics, encompassing digital imaging devices, health and fitness gadgets, home theater systems, portable audio solutions (like headphones and speakers), and smart home products. Beyond electronics, Best Buy also supplies household appliances such as dishwashers, laundry machines, ovens, refrigerators, blenders, coffee makers, and vacuum cleaners.…
1 unmapped firm rating excluded from the percentages.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Loop Capital | Hold | Buy | Downgrade | Jul 13, 2026 |
| DA Davidson | Buy | Buy | Maintain | Jun 22, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | May 29, 2026 |
| Wedbush | Neutral | Neutral | Maintain | May 29, 2026 |
| UBS | Neutral | Buy | Downgrade | May 29, 2026 |
| Truist Securities | Hold | Hold | Maintain | May 29, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | May 29, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | May 29, 2026 |
| Guggenheim | Buy | Buy | Maintain | May 29, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | May 29, 2026 |
| Citigroup | Neutral | Neutral | Maintain | May 29, 2026 |
| Jefferies | Buy | Buy | Maintain | May 28, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Mar 4, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Mar 4, 2026 |
| BNP Paribas | Neutral | Neutral | Maintain | Mar 4, 2026 |
| Telsey Advisory Group | Outperform | Outperform | Maintain | Feb 24, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jan 8, 2026 |
| Argus Research | Hold | Hold | Maintain | Sep 16, 2025 |
| B of A Securities | Underperform | Underperform | Maintain | Aug 29, 2025 |
| Keybanc | Sector Weight | Maintain | Mar 5, 2025 | |
| Credit Suisse | Neutral | Neutral | Maintain | May 26, 2023 |
| Exane BNP Paribas | Neutral | Outperform | Downgrade | Jan 12, 2023 |
| R5 Capital | Sell | Buy | Downgrade | Jul 28, 2022 |
| Raymond James | Market Perform | Outperform | Downgrade | Mar 4, 2022 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Feb 26, 2021 |
| Oppenheimer | Perform | Outperform | Downgrade | Oct 23, 2020 |
| Nomura Instinet | Neutral | Neutral | Maintain | May 22, 2020 |
| Nomura | Neutral | Neutral | Maintain | May 22, 2020 |
| CFRA | Buy | Buy | Maintain | May 21, 2020 |
| PiperJaffray | Overweight | Overweight | Maintain | Nov 27, 2019 |
| Bank of America | Underperform | Neutral | Downgrade | Dec 17, 2018 |
| Deutsche Bank | Hold | Hold | Maintain | Aug 29, 2018 |
| B. Riley FBR | Buy | Neutral | Upgrade | May 5, 2018 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Aug 24, 2016 |
| Stifel Nicolaus | Buy | Buy | Maintain | Nov 17, 2014 |
| Stifel | Buy | Buy | Maintain | Nov 17, 2014 |
| B. Riley Securities | Buy | Neutral | Upgrade | Aug 20, 2013 |
| Standpoint Research | Hold | Buy | Downgrade | Mar 5, 2013 |
| BB&T Capital | Buy | Hold | Upgrade | Jan 28, 2013 |
| Zacks Investment Research | Underperform | Neutral | Downgrade | Aug 24, 2012 |
| Bank oferica | Underperform | Underperform | Maintain | May 23, 2012 |
Upside is calculated against the persisted current price $87.82. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Loop Capital Markets | Analyst unavailable | $82 | $82.8 | -6.6% | Jul 13, 2026 |
| Telsey Advisory | Jospeh Feldman | $90 | $74.74 | +2.5% | May 29, 2026 |
| UBS | Michael Lasser | $86 | $74.74 | -2.1% | May 29, 2026 |
| Piper Sandler | Analyst unavailable | $77 | $76.21 | -12.3% | May 28, 2026 |
| Jefferies | Analyst unavailable | $89 | $76.24 | +1.3% | May 28, 2026 |
| UBS | Michael Lasser | $85 | $62.68 | -3.2% | May 26, 2026 |
| Wells Fargo | Analyst unavailable | $60 | $55.52 | -31.7% | May 14, 2026 |
| Evercore ISI | Analyst unavailable | $65 | $60.85 | -26.0% | Apr 14, 2026 |
| D.A. Davidson | Michael Baker | $78 | $66.06 | -11.2% | Mar 5, 2026 |
| Evercore ISI | Greg Melich | $75 | $67.6 | -14.6% | Mar 4, 2026 |
| Piper Sandler | Peter Keith | $68 | $67.71 | -22.6% | Mar 4, 2026 |
| Truist Financial | Scot Ciccarelli | $66 | $65.95 | -24.8% | Mar 3, 2026 |
| Piper Sandler | Analyst unavailable | $71 | $64.48 | -19.2% | Feb 23, 2026 |
| Wells Fargo | Analyst unavailable | $70 | $66.1 | -20.3% | Feb 18, 2026 |
| Evercore ISI | Analyst unavailable | $70 | $65.9 | -20.3% | Feb 3, 2026 |
| Truist Financial | Scot Ciccarelli | $73 | $68.14 | -16.9% | Jan 16, 2026 |
| Morgan Stanley | Simeon Gutman | $76 | $66.68 | -13.5% | Jan 15, 2026 |
| Barclays | Seth Sigman | $77 | $68.83 | -12.3% | Jan 8, 2026 |
| Truist Financial | Analyst unavailable | $77 | $72.6 | -12.3% | Dec 17, 2025 |
| Evercore ISI | Greg Melich | $80 | $72.56 | -8.9% | Dec 9, 2025 |
| Truist Financial | Analyst unavailable | $84 | $81.05 | -4.3% | Nov 26, 2025 |
| Morgan Stanley | Simeon Gutman | $82 | $81.24 | -6.6% | Nov 26, 2025 |
| UBS | Michael Lasser | $96 | $79.66 | +9.3% | Nov 26, 2025 |
| Barclays | Seth Sigman | $81 | $79.62 | -7.8% | Nov 25, 2025 |
| Jefferies | Jonathan Matuszewski | $95 | $76.77 | +8.2% | Oct 8, 2025 |
| Truist Financial | Analyst unavailable | $72 | $73.64 | -18.0% | Aug 29, 2025 |
| Wells Fargo | Analyst unavailable | $75 | $72.66 | -14.6% | Aug 29, 2025 |
| Piper Sandler | Peter Keith | $75 | $70.95 | -14.6% | Jul 14, 2025 |
| Loop Capital Markets | Analyst unavailable | $90 | $78.6 | +2.5% | Mar 6, 2025 |
| Telsey Advisory | Analyst unavailable | $100 | $75.53 | +13.9% | Mar 5, 2025 |
| UBS | Analyst unavailable | $105 | $75.53 | +19.6% | Mar 5, 2025 |
| Guggenheim | Analyst unavailable | $90 | $75.53 | +2.5% | Mar 5, 2025 |
| Truist Financial | Analyst unavailable | $81 | $75.53 | -7.8% | Mar 5, 2025 |
| Wells Fargo | Analyst unavailable | $85 | $75.53 | -3.2% | Mar 5, 2025 |
| Morgan Stanley | Analyst unavailable | $85 | $75.53 | -3.2% | Mar 5, 2025 |
| Guggenheim | Steven Forbes | $105 | $87.8 | +19.6% | Nov 29, 2024 |
| Melius Research | Karen Short | $100 | $97.05 | +13.9% | Sep 23, 2024 |
| Wedbush | Seth Basham | $95 | $100 | +8.2% | Aug 30, 2024 |
| Loop Capital Markets | Anthony Chukumba | $110 | $100 | +25.3% | Aug 30, 2024 |
| Evercore ISI | Greg Melich | $94 | $100.18 | +7.0% | Aug 30, 2024 |
| Piper Sandler | Peter Keith | $114 | $100.18 | +29.8% | Aug 30, 2024 |
| Barclays | Seth Sigman | $95 | $100.18 | +8.2% | Aug 30, 2024 |
| Jefferies | Jonathan Matuszewski | $116 | $99.64 | +32.1% | Aug 29, 2024 |
| Bank of America Securities | Elizabeth Suzuki | $70 | $88.91 | -20.3% | Aug 27, 2024 |
| UBS | Michael Lasser | $106 | $87.21 | +20.7% | Jun 17, 2024 |
| Loop Capital Markets | Anthony Chukumba | $100 | $88.82 | +13.9% | Jun 7, 2024 |
| Truist Financial | Scot Ciccarelli | $86 | $81.55 | -2.1% | May 31, 2024 |
| Evercore ISI | Greg Melich | $90 | $81.55 | +2.5% | May 31, 2024 |
| D.A. Davidson | Michael Baker | $90 | $81.55 | +2.5% | May 30, 2024 |
| Jefferies | Jonathan Matuszewski | $94 | $80.86 | +7.0% | Apr 8, 2024 |
| Telsey Advisory | Best Buy | $95 | $81.66 | +8.2% | Mar 22, 2024 |
| Telsey Advisory | Jospeh Feldman | $95 | $78.59 | +8.2% | Mar 20, 2024 |
| Truist Financial | Scot Ciccarelli | $87 | $78.4 | -0.9% | Mar 1, 2024 |
| Telsey Advisory | Joseph Feldman | $75 | $79.68 | -14.6% | Feb 29, 2024 |
| Wedbush | Seth Basham | $75 | $75.48 | -14.6% | Feb 8, 2024 |
| Wedbush | Seth Basham | $70 | $67.84 | -20.3% | Nov 22, 2023 |
| Goldman Sachs | Kate McShane | $85 | $70.09 | -3.2% | Oct 19, 2023 |
| Telsey Advisory | Joseph Feldman | $78 | $78.89 | -11.2% | Aug 21, 2023 |
| Telsey Advisory | Joseph Feldman | $81 | $70.63 | -7.8% | May 19, 2023 |
| Barclays | Analyst unavailable | $88 | $87.79 | +0.2% | Feb 8, 2023 |
| Credit Suisse | Analyst unavailable | $90 | $79.8 | +2.5% | Dec 20, 2022 |
| Goldman Sachs | Analyst unavailable | $83 | $81.81 | -5.5% | Dec 12, 2022 |
| Wedbush | Seth Basham | $85 | $81.55 | -3.2% | Nov 23, 2022 |
| Citigroup | Analyst unavailable | $72 | $80.99 | -18.0% | Nov 23, 2022 |
| Goldman Sachs | Analyst unavailable | $59 | $79.88 | -32.8% | Nov 23, 2022 |
| Telsey Advisory | Analyst unavailable | $88 | $79.88 | +0.2% | Nov 23, 2022 |
| J.P. Morgan | Analyst unavailable | $78 | $71.43 | -11.2% | Nov 18, 2022 |
| Guggenheim | Steven Forbes | $85 | $78.54 | -3.2% | Aug 8, 2022 |
| D.A. Davidson | Michael Baker | $110 | $83.99 | +25.3% | May 31, 2022 |
| Wedbush | Seth Basham | $80 | $73.47 | -8.9% | May 24, 2022 |
| Truist Financial | Scot Ciccarelli | $83 | $72.36 | -5.5% | May 21, 2022 |
| Telsey Advisory | Joe Feldman | $130 | $106.1 | +48.0% | Mar 4, 2022 |
| CFRA | Ken Leon | $100 | $109.16 | +13.9% | Mar 3, 2022 |
| Citigroup | Steven Zaccone | $87 | $95.78 | -0.9% | Feb 28, 2022 |
| Bank of America Securities | Elizabeth Lane Suzuki | $147 | $95.78 | +67.4% | Feb 28, 2022 |
| Morgan Stanley | Simeon Gutman | $110 | $97.76 | +25.3% | Jan 18, 2022 |
| Truist Financial | Scot Ciccarelli | $108 | $100.04 | +23.0% | Jan 17, 2022 |
| R5 Capital | Scott Mushkin | $140 | $103.03 | +59.4% | Dec 6, 2021 |
| D.A. Davidson | Michael Baker | $135 | $119.24 | +53.7% | Aug 25, 2021 |
| Barclays | Adrienne Yih | $100 | $119.24 | +13.9% | Aug 25, 2021 |
| Wedbush | Seth Basham | $130 | $119.24 | +48.0% | Aug 25, 2021 |
| Loop Capital Markets | Anthony Chukumba | $150 | $113.85 | +70.8% | Jun 7, 2021 |
Track every rating change on BBY the moment it posts. Free to start.
Start freeFollow BBY with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeRevenue of $8.94 billion edged the $8.82 billion consensus by 1.3%, and EPS of $1.28 beat the $1.23 estimate by 4.1%. Comparable sales grew 2% with expanded operating margin. The stock surged on the report, posting an abnormal move of 15.3% versus the benchmark and continued drift of roughly 4% in subsequent sessions, on volume 3.8x the baseline.
Management reaffirmed full-year FY27 guidance. The guidance sentiment was maintained, with no upward or downward revision communicated on the call.
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.